BL
NWBO

Bolton LP’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Bolton LP’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50,000
Closed -$369K – 210
2015
Q1 		$369K Buy
+50,000
New +$336K 0.1% 88
2014
Q3 		– Sell
-22,300
Closed -$150K – 164
2014
Q2 		$150K Buy
+22,300
New +$142K 0.02% 119

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CWM
CIBC World Markets New York $20.8B AUM

Bolton LP's NWBO Position: Q2 2015 in Review

Bolton LP sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2015, closing a stake of 50,000 shares — an estimated $369K sold.

Bolton LP first reported a position in NWBO in Q2 2014 and held it in 2 quarters. The position peaked at $369K in Q1 2015. 83 funds tracked by Wall St. Rank hold NWBO as of Q2 2015.

  • Bolton LP reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2015 after selling out during the quarter.
  • Bolton LP sold 50,000 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2015, an estimated $369K.
  • Bolton LP first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 2 quarters.
  • Bolton LP's Northwest Biotherapeutics, Inc. Common stock position peaked at $369K in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2015.

Based on Bolton LP's 13F filing for Q2 2015, filed 12 Aug 2015.